case studies
Real Clients. Real Results.
Biopharmaceutical Policy Analysis and Advocacy Strategy
Worked with a premier industry trade association on legislative, regulatory and market access issues across government payers and commercial markets.
Remote Therapeutic Monitoring
ADVI worked with the client and the AMA’s Digital Medicine Payment Advisory Committee to develop new CPT codes for remote therapeutic monitoring.
Cardiovascular Technologies
Reviewed primary clinical study literature and, based on published Medicare precedents and processes, produced mock National Coverage Determinations on several invasive cardiovascular technologies, applying typical CMS standards and formats.
Lumbar Spine Stenosis Device
ADVI worked with the client and CMS to reverse a negative draft NCD and obtained a final NCD with CED that required a randomized clinical study.
Non-Opioid Device Pain Relief Product
Assessed the positioning of a client's non-opioid pain relief device versus competitive products, including drugs and other devices used to treat pain.
AI Device for Osteoporosis Assessment
ADVI helped a client obtain a new Category I CPT code for the trabecular bone score AI software device.
Osseochondral Knee Implant
ADVI analyzed the reimbursement environment for a novel osseochondral implant under development to determine whether existing codes and payment would be sufficient for the new device.
Wound Product
Repositioned a struggling wound care device away from dressings and obtained a new CPT code allowing a physician or qualified healthcare professional to dispense the device as part of a professional service.
Diabetic Devices and Supplies
Tracked historical CMS reimbursement changes for diabetic devices and supplies and evaluated the impact Medicare payment rates had on commercial pricing so the client was able to better understand and prepare internal forecasting for how newly proposed regulations may affect commercial plans rates in the future.
Product Positioning for a Novel Cancer Therapy
ADVI assisted a client in Phase II development of a novel cancer therapy in preparing for launch, holding discussions with potential commercial payers and CMS.
Launch Roadmap for a Novel Vaccine
A global pharmaceutical client asked ADVI to support the launch of a novel vaccine with multiple intended uses.
Commercial Strategy for Orphan Disease Commercial Strategy
To support the pre-launch reimbursement planning for a global pharmaceutical client’s novel orphan drug with multiple uses – including maternal fetal – ADVI developed a payor plan, a reimbursement landscape, as well as a coding strategy
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.